Lv0
0 积分 2025-06-28 加入
Aptamer‐RIBOTAC Strategy Enabling Tumor‐Specific Targeted Degradation of MicroRNA for Precise Cancer Therapy
9个月前
已完结
Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function
10个月前
已完结
Exploring the next generation of antibody–drug conjugates
10个月前
已完结
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
10个月前
已完结
皖公网安备34019202002308
